Albertsons Companies Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
-5.1%projected annual EPS growth
Analyst Coverage
16analysts covering
Monitoring Framework
Key Performance Indicators
Identical Sales Growth Annually70.0%Target: 0.0% to 1.0%
Digital Sales Growth Annually1,600.0%
Loyalty Program Members Quarterly51.2M
Watch Items
- Inflation Reduction Act (IRA) Medicare Drug Price Negotiation ImpactTrigger: 150 basis point headwind on identical salesAction: Monitor pharmacy segment sales mix and gross margin compression sequentially through fiscal 2026.
- Opioid Settlement Framework PaymentsTrigger: $774 million pre-tax settlement recorded in Q4 FY2025Action: Track cash flow impacts of the settlement payments scheduled over a 9-year period.
- Standalone Capital Allocation and Share RepurchasesTrigger: $2.0 billion remaining share repurchase authorizationAction: Monitor execution of the planned ~$600 million in share repurchases during fiscal 2026.
Research as of 19 Jun 2026